Professor Ruth Gilbert of University College London presents "Could a systematic review have prevented the epidemic of sudden infant death syndrome?" at the opening of the Austrian Cochrane Branch in Krems, Austria, on December 14th 2010.
Professor Marcus Müllner of the Austrian Agency for Health and Food Safety (AGES) presents "Does evidence-based decision making exist?" at the opening of the Austrian Cochrane Branch on December 14th, 2010 in Krems.
Introduction and welcome to the opening by Dr. Kylie Thaler, Associate Director of the Austrian Cochrane Branch. Followed by a presentation by Sir Iain Chalmers on the James Lind Library initiative. December 14th, 2010, In Krems, Austria.
Professor Marcus Müllner of the Austrian Agency for Health and Food Safety (AGES) presents "Does evidence-based decision making exist?" at the opening of the Austrian Cochrane Branch on December 14th, 2010 in Krems.
Introduction and welcome to the opening by Dr. Kylie Thaler, Associate Director of the Austrian Cochrane Branch. Followed by a presentation by Sir Iain Chalmers on the James Lind Library initiative. December 14th, 2010, In Krems, Austria.
Practical considerations in the control of a Rift Valley fever epizooticmarketsblog
Presentation by Dr Peter Ithondeka, Director of Veterinary Services,Kenya, at the Enhancing Safe Inter-regional Livestock Trade workshop held at Dubai, UAE, 13-16 June 2011.
By Juliane Ried 1, Gavin Stewart 2, David Hives 2, Martin Janczyk 3, Lorne Becker 4
1 Cochrane Innovations, Germany; 2 The Cochrane Library, Wiley, UK; 3 Cochrane Web Team, Germany; 4 Cochrane Innovations, USA
Dr. Gerd Antes, Director of the German Cochrane Centre, presents "Evidenz ist essentiell - von der Idee zum globalen Netzwerk: Die Cochrane Collaboration".
Balancing benefits and risks of drug treatment: how to combine the best randomized evidence on benefit with the best observational data about adverse effects
Cochrane Colloquium 2008 - Closing Session
More Related Content
Similar to 3. Opening of the Austrian Cochrane Branch - Ruth Gilbert
Practical considerations in the control of a Rift Valley fever epizooticmarketsblog
Presentation by Dr Peter Ithondeka, Director of Veterinary Services,Kenya, at the Enhancing Safe Inter-regional Livestock Trade workshop held at Dubai, UAE, 13-16 June 2011.
Similar to 3. Opening of the Austrian Cochrane Branch - Ruth Gilbert (6)
By Juliane Ried 1, Gavin Stewart 2, David Hives 2, Martin Janczyk 3, Lorne Becker 4
1 Cochrane Innovations, Germany; 2 The Cochrane Library, Wiley, UK; 3 Cochrane Web Team, Germany; 4 Cochrane Innovations, USA
Dr. Gerd Antes, Director of the German Cochrane Centre, presents "Evidenz ist essentiell - von der Idee zum globalen Netzwerk: Die Cochrane Collaboration".
Balancing benefits and risks of drug treatment: how to combine the best randomized evidence on benefit with the best observational data about adverse effects
Cochrane Colloquium 2008 - Closing Session
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
3. Opening of the Austrian Cochrane Branch - Ruth Gilbert
1. "Could a systematic review have
prevented the epidemic of sudden
infant death syndrome?"
Ruth Gilbert
Centre for Evidence-based Child Health
UCL Institute of Child Health, London,
UK
3. Advice on infant sleeping position
“Avoid prone (front)
sleeping, particularly
at night.” (review of
139 deaths)
–Abramson 1944
1944 1950 1960 1970 1980 1990 2000 2005
Rubber sheet
experiment.
- “suffocation
unlikely”
Woolley 1945
4. Advice on infant sleeping position
1944 1950 1960 1970 1980 1990 2000 2005
SIDS
Infection/inhalation?
Front sleeping
Scoliosis, rounded heads
Apnoeas, oxygenation
Sleeps better
5. UK
How did practice change?
Netherlands
Norw ay
Prevalence of prone sleeping
New Zealand
75 Australia
Hong Kong
USA
65
55
USA NTL
45
% prone
35
25
15
5
1955 1960 1965 1970 1975 1980 1985 1990 1995 2000
-5
midpoint date
6. How did SIDS
incidence
change?
Arch Dis Child
1995;72:478-82.
10. Can we infer causality?
• RCTs feasible in 1970 but not after
• Evidence only from systematic review of
observational studies
• But….
– Strong association
– Not explained by confounders
– Dose effect (side, front vs back)
– SIDS reduced when front sleeping declined
11. Change in SIDS incidence as front sleeping declined
Postneonatal SIDS: England & Wales
2.5
deaths/1000 live births
2
1.5
1
0.5 Avon
campaign National
campaign
0
74
76
78
80
82
84
86
88
90
92
94
96
98
19
19
19
19
19
19
19
19
19
19
19
19
19
year
Source: Office of National Statistics
12. SIDS incidence: Europe 1987-1997
Change in 5
Austria E&W NTL Norway Scotland Switz
SIDS 4
rate/1000
3
incidence 2
1
0
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
SIDS incidence 1987-1997
Excess death toll Australia NZ USA
due to prone 5
sleeping in 20y 4
rate/1000
3
USA>40,000
2
UK >10,000 1
0
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
13. Lessons
1) Clinical practice requires clinical evidence
2) Delays in systematically reviewing evidence can
cost lives
3) Systematic reviews – can help to explain
conflicting results
14. "Could a systematic review have
prevented the epidemic of sudden
infant death syndrome?"
Possibly!
15. Why did it take so long to change advice?
De Jonge (NTL)
1944 1950 1960 1970 1980 1990 2000 2005
SIDS foundation (UK)
Government advice
USA
16. Acknowledgements
• Georgia Salanti, Sarah See, Melissa Harden
(co-authors), Chris Hiley, Iain Chalmers
Gilbert, Salanti, Harden, See. Int J Epid 2005
r.gilbert@ich.ucl.ac.uk